|4Mar 8, 5:29 PM ET

Hadfield Robert 4

4 · ZIOPHARM ONCOLOGY INC · Filed Mar 8, 2021

Insider Transaction Report

Form 4
Period: 2021-03-04
Hadfield Robert
General Counsel and Secretary
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-03-04+326,250326,250 total
    Exercise: $4.31Exp: 2031-03-04Common Stock (326,250 underlying)
  • Award

    Common Stock

    2021-03-04+43,500176,819 total
Footnotes (2)
  • [F1]10,875 shares shall vest on each of 12/31/2021, 12/31/2022, 12/31/2023 and 12/31/2024.
  • [F2]1/16th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION